therapeutic strategies to maximize sensitivity to endocrine therapy in breast cancer
Published 1 year ago • 124 plays • Length 1:00Download video MP4
Download video MP3
Similar videos
-
1:14
endocrine therapy resistance in er metastatic breast cancer
-
6:23
stratifying patients with breast cancer by a 7-gene assay for endocrine therapy
-
3:44
alternate: neoadjuvant endocrine treatment in er /her2- breast cancer
-
5:01
cdk4/6 inhibitors: sequencing endocrine therapy for metastatic breast cancer
-
1:27
treating er breast cancer patients with endocrine therapy resistance
-
4:05
prescribing practices of endocrine therapy for premenopausal breast cancer patients in mexico
-
8:18
endocrine therapy in premenopausal women with hr breast cancer
-
6:48
how to use endocrine therapy in premenopausal women with er early breast cancer
-
1:08
overcoming resistance to cdk4/6 inhibitors in er breast cancer via ctdna
-
0:55
cambria-1: camizestrant vs standard endocrine therapy in breast cancer
-
5:00
penelope-b: palbociclib with endocrine therapy in hr , her2-negative breast cancer
-
1:02
combination therapies incorporating adcs in breast cancer
-
1:08
the role of immunotherapy in endocrine-refractory luminal breast cancer
-
17:54
expert perspectives: cdk 4/6 inhibitors for er breast cancer: current data and clinical use
-
1:43
composite biomarkers predictive of palbociclib endocrine treatment benefit in early breast cancer
-
6:29
study of palbociclib after cdk & endocrine therapy in er /her2- metastatic breast cancer
-
20:13
endocrine treatment in breast cancer
-
4:45
using ai to improve mammograms in breast cancer screening
-
3:15
investigating targeted therapy combinations in metastatic hr breast cancer